sábado, 2 de marzo de 2019

Pharmaceutical interventions to improve safety of chemotherapy-treated cancer patients: a cross-sectional study. | AHRQ Patient Safety Network

Pharmaceutical interventions to improve safety of chemotherapy-treated cancer patients: a cross-sectional study. | AHRQ Patient Safety Network

PSNet email header

  • Study
  •  
  • Published January 2019

Pharmaceutical interventions to improve safety of chemotherapy-treated cancer patients: a cross-sectional study.



    Prior research has shown that oncology pharmacists can improve the safety of chemotherapy administration. In this prospective study, researchers found that 129 of 1346 chemotherapy prescriptions issued in a 1-month period at a single university hospital required intervention by an oncology pharmacist. The majority of such interventions were perceived as having a significant impact on patient safety.














    View More

    No hay comentarios: